Clinical Trials Browser

methylnaltrexone × Other × Clear all

NCT00858754 2019-11-29

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Phase 4 Withdrawn

Opioid-Induced Constipation

NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Phase 2 Completed

12 enrolled 10 charts

Constipation, Opioid-Related Disorders, Neoplasms